|
Phenotype Submission - Congenital Heart Disease
|
|
1
|
117
|
September 16, 2023
|
|
Phenotype Submission - Pulmonary hypertension associated with lung diseases and/or hypoxia (WHO Group 3)
|
|
2
|
169
|
September 16, 2023
|
|
Phenotype Submission - Pulmonary hypertension associated with left heart disease (WHO Group 2)
|
|
2
|
331
|
September 16, 2023
|
|
Phenotype Submission - Scleroderma
|
|
1
|
127
|
September 16, 2023
|
|
Phenotype Submission - Sickle Cell Anemia
|
|
1
|
122
|
September 16, 2023
|
|
Phenotype Submission - Sarcoidosis
|
|
1
|
150
|
September 16, 2023
|
|
Phenotype Submission - Right Heart Failure
|
|
1
|
155
|
September 16, 2023
|
|
Phenotype Submission - PAH Drug Treatment Groups
|
|
1
|
147
|
September 16, 2023
|
|
Phenotype Submission - PAH plus Left Heart Disease
|
|
1
|
112
|
September 16, 2023
|
|
Phenotype Submissions - HowOften - Dual biologic therapy for IBD, PsO, and PsA
|
|
1
|
129
|
September 16, 2023
|
|
Phenotype Submission - Non-infectious uveitis and iridocyclitis
|
|
1
|
165
|
September 15, 2023
|
|
Phenotype Submission - Down Syndrome
|
|
1
|
146
|
September 15, 2023
|
|
Phenotype Submission - Motor Vehicle Accidents (MVA)
|
|
1
|
207
|
September 15, 2023
|
|
Phenotype Submission - Pulmonary Arterial Hypertension (WHO Group 1)
|
|
1
|
174
|
September 14, 2023
|
|
Phenotype Submission - Pulmonary Hypertension
|
|
1
|
164
|
September 14, 2023
|
|
Phenotype submission - Diabetic ketoacidosis
|
|
1
|
161
|
September 8, 2023
|
|
Nested criteria interpretation
|
|
1
|
162
|
September 7, 2023
|
|
Call for collaboration - Myasthenia Gravis PROJECT
|
|
0
|
135
|
September 7, 2023
|
|
Characterization - defining treatment combinations
|
|
0
|
141
|
September 6, 2023
|
|
Characterization - subgroup analysis
|
|
0
|
126
|
September 6, 2023
|
|
Cohort pathways - collapse days
|
|
2
|
355
|
September 5, 2023
|
|
Visit type on index date
|
|
0
|
168
|
August 30, 2023
|
|
Location information in Atlas (Geography, State)
|
|
4
|
276
|
August 28, 2023
|
|
Phenotype Submission – Blinding diseases (diabetic retinopathy/diabetic macular edema, age-related macular degeneration, macular edema, and retinal vein occlusion)
|
|
1
|
158
|
August 27, 2023
|
|
Phenotype Submission - new users of 3 monthly intravitreal anti-VEGF (aflibercept, bevacizumab, ranibizumab)
|
|
1
|
147
|
August 27, 2023
|
|
Call for collaborators: Trial Replication Through Observational Study of Yonsei (TROY) Project
|
|
2
|
196
|
August 23, 2023
|
|
Phenotype Submission - Endometriosis
|
|
3
|
365
|
August 23, 2023
|
|
Phenotype Submission - Endometriosis
|
|
4
|
637
|
August 22, 2023
|
|
Denominator cohort for incidence rate analysis
|
|
1
|
218
|
August 22, 2023
|
|
ATLAS Incidence Rate cohort total
|
|
3
|
231
|
August 22, 2023
|
